Skip to Main Content
An official website of the United States government

Approved PLCO Projects

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
How effective is PSA Screening as a mode of prevention for Prostate Cancer in Men over the age of 50? Jiana Karthikeyan Franconian International School PLCO Apr 29, 2024 PLCO-1543
A novel accuracy metric for general M-class classification when subclasses are involved Nan Nan State University of New York at Buffalo PLCO Apr 29, 2024 PLCO-1531
Development and Validation of In-House Artificial Intelligence Models for Mutation and Survival Prediction Nikolaos Tsiknakis Karolinska Institutet PLCO Apr 29, 2024 PLCOI-1539
Development of a Woman-Specific Risk Model for Participation in Lung Cancer CT Screening Marie-Pierre Revel APHP PLCO Apr 29, 2024 PLCO-1538
Prototype System for Supporting Urologists in Bladder Tumor Detection Jaime Hugo Puebla Lomas Instituto Politécnico Nacional PLCO Apr 18, 2024 PLCOI-1527
Is Supervised machine learning algorithm comparative over nomograms in predicting biochemical recurrence after prostatectomy: a validation study Kheng Sit Lim AiM Medical Pte Ltd PLCO Apr 18, 2024 PLCO-1533
Predicting cancer-specific mortality using histopathology slides Shu Jiang Washington University in St. Louis PLCO Apr 18, 2024 PLCOI-1532
AI/ML based risk analysis for early cancer detection and prevention for high-risk, understudied, and/or underserved cancer populations. Amalendu Ranjan UNT Health Science Center PLCO Apr 18, 2024 PLCO-1529
Precision nutrition approaches to prostate cancer prevention: role of insulinemic dietary patterns on lethality Fred Tabung The Ohio State University Comprehensive Cancer Center PLCO Apr 16, 2024 2023-0064
Using Interpretable and (Explainable) Ensemble Methods to Unpack Disease Predictions: An Empirical Study of the Cancer Prediction Problem Gorkem Turgut Ozer University of New Hampshire PLCO Apr 12, 2024 PLCO-1530
The relevance of co-morbidities and other modifiable risk factors beyond BMI in determining prognosis among gynecologic cancers Mauricio Cuello Pontificia Universidad Católica de Chile PLCO Apr 10, 2024 PLCO-1457
Role of dietary intake in cancer survival Maryam Farvid George Mason University PLCO Apr 3, 2024 PLCO-1511
Neural Network AI detection of Breast cancer (Education) Hudson Leslie Kingwood Park High School PLCO Apr 2, 2024 PLCO-1524
Integrating AI-Driven Analysis of Clinical and Imaging Data to Optimize Lung Cancer Treatment Strategies Ricardo Gonzales Vera University of Oxford PLCO Apr 2, 2024 PLCOI-1517
WARIFA - Watching the Risk Factors Giovanni Sebastiani Institute for applied mathematics "Mauro Picone" (IAC) PLCO Apr 2, 2024 PLCO-1521
Covariate data for new set of controls for GWAS studies Rachael Stolzenberg-Solomon DCEG, NCI PLCO Mar 27, 2024 PLCO-1515
Enhancing Lung Cancer Treatment Decisions through AI-driven Analysis of PLCO Patient Data Ricardo Gonzales Vera University of Oxford PLCO Mar 27, 2024 PLCO-1514
Pan-cancer analyses of imaging-clinical phenotype associations using updated PLCO cohorts Kun-Hsing Yu President and Fellows of Harvard College PLCO Mar 25, 2024 PLCOI-1509
Clarifying Lung Cancer Risk Among Prostate Cancer Survivors Keith Sigel Icahn School of Medicine at Mount Sinai PLCO Mar 25, 2024 PLCO-1508
Identifying novel genetic factors predisposing to inherited cardiac disorders Connie Bezzina Amsterdam Universitair Medisch Centrum PLCO Mar 25, 2024 PLCO-1507